Jump to ContentJump to Main Navigation
Me Medicine vs. We MedicineReclaiming Biotechnology for the Common Good$
Users without a subscription are not able to see the full content.

Donna Dickenson

Print publication date: 2016

Print ISBN-13: 9780231159753

Published to Columbia Scholarship Online: November 2015

DOI: 10.7312/columbia/9780231159753.001.0001

Show Summary Details
Page of

PRINTED FROM COLUMBIA SCHOLARSHIP ONLINE (www.columbia.universitypressscholarship.com). (c) Copyright University of Minnesota Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in CUPSO for personal use.date: 10 May 2021

Pharmacogenetics: One Patient, One Drug?

Pharmacogenetics: One Patient, One Drug?

(p.62) 3 Pharmacogenetics: One Patient, One Drug?
Me Medicine vs. We Medicine

Donna Dickenson

Columbia University Press

This chapter focuses on the components and implications of pharmacogenetics, which refers to the relationship between heritable variations and individual differences in drug response. Pharmacogenetics aims to alter pharmaceutical patterns in cancer treatment and other branches of medicine in accordance to the patient’s individual genome. Some commentators believe that investment in pharmacogenetics is the most effective way to deliver the public health welfare originally pledged by the Human Genome Project. The chapter aims to devise a balanced judgment about pharmacogenetics, taking into consideration not only the medical evidence but also issues about justice, patenting, and drug rationing—including issues surrounding BiDil, a controversial personalized drug.

Keywords:   pharmacogenetics, individual drug response, cancer treatment, Human Genome Project, justice, patenting, drug rationing, BiDil

Columbia Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us .